AKT1 and lung cancer: Mechanistically, our data show that β-elemene significantly downregulates LINC00511 expression, leading to inhibition of the PI3K/AKT/mTOR signaling pathway—a well-established driver of chemoresistance in lung cancer (Glaviano et al., 2023).